Skip to main content
. 2023 Jul 1;2(7):902–910. doi: 10.1016/j.gastha.2023.06.005

Figure 3.

Figure 3

Proportion of neoplasia found at positive (+) multitarget stool DNA (mt-sDNA) colonoscopy among average-risk patients with bariatric and metabolic surgery (BMS) compared to: (A) average-risk patients with +mt-sDNA and no history of BMS, (B) BMS patients with screening colonoscopy alone.